![Ticagrelor [274693-27-5] Ticagrelor [274693-27-5]](https://www.targetmol.com/group3/M00/35/45/CgoaEGayGnCEEMs5AAAAAD-aQPY742.png)
Ticagrelor [274693-27-5]
T0179
Overview
- SupplierTargetMol Chemicals
- Product NameTicagrelor [274693-27-5]
- Delivery Days Customer4
- CAS Number274693-27-5
- Category SupplierChemical
- CertificationResearch Use Only
- Chemical NameTicagrelor
- Molecular FormulaC23H28F2N6O4S
- Molecular Weight522.57
- Scientific DescriptionTicagrelor (AR-C 126532XX), produced by AstraZeneca, is an inhibitor of platelet aggregation. Unlike clopidogrel, ticagrelor is not a prodrug required metabolic activation. The drug was approved for use in the European Union by the European Commission on December 3, 2010, and by the US FDA on July 20, 2011. Its trade names are Brilinta (US), Brilique(EU) and Possia(EU).
- Shelf life instruction3 years
- SMILESCCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1
- Storage Instruction-20°C
- UNSPSC12352200